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1119: DIFFERENTIAL EXPRESSION AND FUNCTION OF MONOCARBOXY-
LATE TRANSPORTER 1 (MCT1) IN HUMAN COLON
Naomi Fearon*,1, Elizabeth Ryan 1, Gavin Stewart 2, Des Winter 1,
Alan Baird 2. 1St Vincents University Hospital, Dublin, Ireland; 2University
College Dublin, Dublin, Ireland.
Introduction: Butyrate, a short-chain fatty acid, is produced by fermen-
tative bacteria in the colon, and is the primary energy source for colono-
cytes. It is transported across the colonic epithelium by monocarboxylate
transporter 1(MCT1). Optimal butyrate production and transport is
imperative for maintenance of gut health.
Methods: Western blot studies and immunohistochemistry detected
expression of MCT1 transporters in the human colon. Butyrate ﬂux studies
were carried out by mounting fresh human colon samples in Using
Chambers. Bidirectional ﬂux was investigated using radiolabelled butyrate
(C14) and Papp determined by using a scintillation counter.
Results: Immunohistochemistry andWestern blotting showed differential
expression of MCT1 throughout the colon. There was stronger expression
in the ascending colon compared to the descending colon (p<0.01, n¼3).
Butyrate ﬂux was bidirectional and was signiﬁcantly greater in the
ascending colon compared to the descending colon (p<0.05, n¼6). Flux
was inhibited by the known butyrate inhibitor Resveratrol.
Conclusions: These results illustrate differential expression of MCT1 in the
human colon, strongly correlating to regions that contain the largest
populations of intestinal bacteria.
1126: COLORECTAL CANCER OPERATIVE NOTES: PRELIMINARY AUDIT
RESULTS
Jessica Veitch*, Thomas Barnes, Nicola Eardley, Michael Johnson,
Chris McFaul, Dale Vimalachandran. Countess of Chester NHS Foundation
Trust, Chester, UK.
Introduction: Structured operative notes are imperative to provide clear
documentation of intraoperative events. In colorectal cancer they are vital
to plan post-operative management and future follow-up as well as aiding
data collection. This audit will assess colorectal cancer operative note
documentation in accordance with Association of Coloproctology (ACP)
Guidelines.
Methods: 50 colorectal resections performed between September 2012
and September 2013 were randomly selected for audit and operative notes
reviewed retrospectively. From these results an operative note proforma
was produced in accordance with ACP guidelines. A re-audit is ongoing
auditing all resections performed since November 2013 with this proforma
in use. Preliminary second cycle results are presented (n¼15).
Results: Full name, DOB and hospital number documentation improved
from 51%, 31% and 39% respectively to 100% each in the second cycle.
Surgeon name was 100% in both cycles though surgeon grade improved
from 2% to 87%. Operation date improved from 71% to 100% and start/end
time improved from 0% to 87%. Operation intention improved from 16% to
87%. Extent of malignancy improved from 61% to 87%.
Conclusions: Preliminary results show that an operative note proforma
has improved documentation in all domains. On-going audit is required to
conﬁrm this.
1139: THE ADDITIONAL YIELD OF WHOLE COLONIC IMAGING TWO
WEEK RULE (TWR) COLORECTAL ASSESSMENT
Nadeem Al-Khafaji*,2, Leonard Quinn 1, Adnan Sheikh 1, Paul Rooney 1.
1Royal Liverpool University Hospital, Liverpool, UK; 2University of Liverpool,
Liverpool, UK.
Introduction: Whole Colonic Investigation (WCI) following negative
Flexible Sigmoidoscopy (FS) in symptomatic patients is thought to have a
low diagnostic yield. We assessed the adequacy of FS in symptomatic TWR
patients and additional yield of neoplasia gained with WCI.
Methods: 2151 TWR patients from January 2012 to June 2013 were ana-
lysed, 404 excluded for non-attendance and anaemia. Endpoints were age-
stratiﬁed FS outcomes and additional colonic/extra-colonic neoplastic
yield of WCI.
Results: 1747 symptomatic patients were included (median age 65) with
91 colorectal cancers. WCI was undertaken in 974(55.8%) patients
following FS. FS initially identiﬁed 285 patients with colorectal neoplasia.Subsequent WCI identiﬁed 112 additional patients. The additional yield of
WCI compared to FS was signiﬁcantly greater, 29 in the 70-79year group
(p¼0.006), 41 in the 60-69year group (p¼0.001) and 28 in the 50-59 year
group (p¼0.01) (Chi-square). In >80year and <49year groups, WCI did not
confer signiﬁcant beneﬁt. 15 missed colorectal and 40 extra-colonic pri-
maries were identiﬁed by WCI.
Conclusions: WCI identiﬁed signiﬁcant numbers of patients with colo-
rectal neoplasia following negative FS. Investigating with FS alone results
in unacceptably high missed colonic and extra-colonic cancers. The role of
FS alone in colorectal TWR workup needs reassessment.
1157: COLORECTAL CANCER IN THE ELDERLY AND THE INFLUENCE OF
LEAD TIME BIAS: BETTER SURVIVAL DOES NOT EQUATE WITH
IMPROVED LIFE EXPECTANCY
K. Knight*, R. Oliphant, F. Maxwell, C. McKenzie, T. Sharma, A. Macdonald.
Lanarkshire Colorectal Study Group, Monklands Hospital, Airdrie, UK.
Introduction: To deﬁne outcomes in all patients presenting with colorectal
cancer aged 80 years at time of diagnosis based on treatment received.
Methods: Patients aged80 diagnosed with colorectal cancer in one acute
hospital trust between 1998 and 2011 were identiﬁed from a prospectively
maintained database. Primary endpoints were age at diagnosis, age at
death/censor and mortality at 30, 90 and 365 days.
Results: Of 668 patients, 412 (61.7%) underwent surgery, 44 (6.6%)
received endoscopic therapy and 212 (31.7%) had no active treatment.
Mean age at diagnosis was younger in those undergoing surgical resection
(83.7 years) compared to those having defunctioning surgery (84.9 years;
P¼0.043), endoscopic therapy (85.1 years; P¼0.008) or those managed
non-surgically (85.6 years; P<0.001). There was no signiﬁcant difference in
mean age of death or censor between groups. 1-year mortality in those
undergoing surgical resection was 30.1% compared to 67.7% in the
defunctioning group, 76.9% after bypass surgery and 63.2% in those who
had no active treatment (Log rank P<0.001).
Conclusions: There was no signiﬁcant difference in age at death or censor
between treatment groups among patients aged 80 presenting with
colorectal cancer, suggesting that differences in observed survival time are
heavily inﬂuenced by lead-time bias.
1233: I’D RATHER TAKE THE STAIRS e AN ALTERNATIVE TO CARDIOPUL-
MONARY EXERCISE TESTING
Alastair Morton*,1, Charles Maxwell-Armstrong 2, Damian Bragg 2,
Chris Harber 2. 1University of Nottingham, Nottingham, UK; 2Nottingham
University Hospitals Trust, Nottingham, UK.
Introduction: To investigate whether a short exercise test and peak
expiratory ﬂow rate (PEFR) can predict post-operative complications in
elective major abdominal surgery.
Methods: 58 patients scheduled for major abdominal surgery aged over 40
were recruited. In addition to the normal preoperative evaluation, patients'
rates of heart rate recovery (HRR) were recorded for twominutes following
a rapid climb of two ﬂights of stairs. Preoperative and postoperative PEFR,
incidence of complications and length of stay (LOS) were recorded.
Results: 48 patients were suitable for analysis; 40 had valid HRR data.
Complications occurred in 24/48 patients (50%). The mean rate of HRR was
signiﬁcantly lower in those who subsequently developed complications
(2.880±1.577 b.p.m/15secs) compared to those who did not (4.493±1.306
b.p.m/15secs) (t (38)¼3.473, p¼0.001), a mean difference of 1.614 (95%CI
0.673-2.554). When adjusted for severity of complication, the R2 value of
association was 0.371 (p<0.001). In patients with co-morbidities, preop-
erative PEFR was 29.7% lower in those who developed complications
(p¼0.022, 95% CI 5.09%-54.31%).
Conclusions: The HRR rate is a quick and cheap alternative to cardiopul-
monary exercise testing to screen for post-operative complication risk.
More data is needed to assess the impact on LOS. PEFR was predictive of
complications in those with co-morbidities.
1248: SURGEON VERSUS GASTROENTEROLOGY COLONOSCOPISTS e DO
SURGEONS NEED TO TRAIN IN ENDOSCOPY?
Qamar Zaman*,1, Aftab Khan 2, Daniel Thomas 1, Rajab Kerwat 1,
Hamid Khawaja 1, John Payne 1. 1Queen Mary Hospital, London, UK;
2University College London, London, UK.
Introduction: To compare the colonoscopy service provision between
gastroenterologists and surgeons at a district general hospital.
Abstracts / International Journal of Surgery 12 (2014) S13eS117S36Methods: We compared all colonoscopy procedures performed by
joint advisory group (JAG) on GI endoscopy approved surgical and gastro-
enterology endoscopists during the period January 2008 till June 2013.
Results: A total of 6718 colonoscopies were performed by 6 gastroenter-
ology and 8 surgeon endoscopists with comparable completion rates. The
surgeons performed twice more colonoscopies (n¼4611) with statistically
signiﬁcant difference in patient's age (62.3 years vs. 57.6 years, p <0.001).
The surgeons also performedmore therapeutic procedures (1529 vs. 442, p
<0.001) with higher polyp excision rates (p 0.001). During the procedures,
surgeons used less sedation (mean dose: Fentanyl dose 55.31 mcg vs. 61.53
mcs, p <0.001; Midazolam 2.6mg vs. 2.7mg, p <0.001) but high dose of
Buscopan (9mg vs. 1.5 mg, p <0.001) resulting in overall less patient
discomfort levels (p 0.001).
Conclusions: The study demonstrates a high volume of diagnostic and
therapeutic colonoscopy service provided by surgeons. This study high-
lights the need for incorporation of endoscopy training into surgical cur-
riculum.
1252: STAPLED ANOPEXY: AN EFFECTIVE TREATMENT FOR SYMPTOM-
ATIC HAEMORRHOIDAL DISEASE e A DISTRICT GENERAL HOSPITAL
EXPERIENCE
Bikesh Dongol*, Johnathan Porter, Ashiq Mohamad, Karim Muhammad.
Tameside General Hospital, Department of General Surgery, Ashton-under-
Lyne, Manchester, UK.
Introduction: A prospective review of our experience and outcomes in a
series of 74 consecutive patients, who underwent stapled anopexy, be-
tween 2011-2013.
Method: Data was collected prospectively. Clinical information was ob-
tained from all patients. Patient demographics, symptoms, indications for
surgery and short-term outcomes were evaluated.
Results: 74 patients with symptomatic haemorrhoidal disease underwent
stapled anopexy, with a male: female ratio of 35:39, mean age of 50 (range
25-85). Pre-operative symptoms included rectal bleeding (84%), perianal
irritation (43%), prolapsing haemorrhoids (30%) and skin tags (7%). Surgery
was performed as a day case procedure. There were no intra-operative
complications. Post-operatively, minor bleeding or discomfort was the
most common complication. No faecal incontinence was noted. 70% of
patients were discharged following 1 routine outpatient appointment,
increasing to 90% after 3 appointments. Of the remaining 10% (8 patients);
4 had underlying obstructive defecation syndrome, 1 had urgency that
settled after 4 months, 1 had delayed wound healing and 2 had painful
defecation of which 1 required excision of a painful suture neuroma.
Conclusions: Multiple treatment modalities exist for symptomatic hae-
morrhoidal disease. Our short-term results demonstrate stapled anopexy
to be an effective treatment with low associated morbidity and a high level
of patient satisfaction.
1259: ASSESSING THE MOST EFFECTIVE UPPER LIMIT OF NORMAL FOR
CEA IN THE FOLLOW UP OF CURATIVE COLORECTAL CANCER RESEC-
TIONS
Jasmine Poonian*, Timothy Bullen, James Arthur. Aintree University Hospital
Trust, Liverpool, UK.
Introduction: Carcino-Embryonic Antigen (CEA) is a marker for recurrent
disease following curative resections of colorectal cancer. Not all colorectal
tumours express CEA and it may be raised for other reasons. A raised CEA
requires investigation but slight rises in CEA frequently fail to demonstrate
recurrent disease and carry risks and promote anxiety. We reviewed CEA
levels at their ﬁrst check post-curative resection and correlated this with
recurrence.
Methods: Retrospective case-note review of 418 patients having curative
resections between 4/9/08 and 24/12/12.
Results: 130 patients developed recurrent disease (ﬁrst CEA range was 0.2
e 11563ng/mL, median 9.2). 288 patients had no recurrent disease (ﬁrst
CEA range 0.5- 112.9ng/mL, median 2.6). Using an upper limit of normal as
3.5ng/mL for CEA the sensitivity and speciﬁcity for recurrent disease is 55%
and 75% however at 4.0ng/mL it is 52% and 83%.
Conclusions: Raising the upper limit of normal is effective in reducing the
number of disease-free patients having needless investigations for recur-
rence (22 patients) however the cost of missing three recurrent carci-
nomas is too high. The best value for the upper limit of normal of CEA is
3.5ng/mL.1298: ERECTILE DYSFUNCTION AND FAECAL INCONTINENCE AFTER PEL-
VIC RECTAL CANCER SURGERY
Wee Sing Ngu, Albert WT. Ngu*, Mohammad Tabaqchali, Talvinder Gill,
Anil Agarwal, Victor Palit, Dharmendra Garg. University Hospital of North
Tees, Stockton-On-Tees, UK.
Introduction: Erectile dysfunction (ED) and faecal incontinence (FI) can
affect 75% of men after pelvic rectal cancer surgery. There is paucity of data,
especially ED as what is accessible is extrapolated from prostate cancer
studies. The aimwas to gauge trust practice and obtain data for prospective
questionnaire planning.
Methods: A retrospective questionnaire (Wexner score and International
Index of Erectile dysfunction (IIEF-5)) was sent to 71 male patients from
January 2011 to December 2012.
Results: Response rate was 47.9%. Patients who felt inappropriately
counselled about ED risk post-operatively was 47%. Of these, 68.8% would
have preferred a discussion regarding ED pre-operatively. On the IIEF-5,
31.2% patients had moderate ED, 12.5% had mild to moderate ED, 25% had
mild ED whilst 31.2% had no ED. In contrast, 35.2% felt inappropriately
counselled about FI risk post-operatively and 83.3% would have preferred
to have had this discussion. Prior to surgery, 58.8% never suffered from FI.
After surgery, 15.2% patients scored 10 or more on the FI score (0 no in-
continence and 20 severe incontinence).
Conclusions: ED and FI are issues that need to be addressed more
comprehensively and patients should be counselled regarding these risks
in a timely manner whilst dealing with the diagnosis of cancer.
1357: THE INDIVIDUAL SURGEON'S PERFORMANCE: 10 YEARS OF LAPA-
ROSCOPIC COLORECTAL SURGERY
Sina Hossaini*, Balamurali Bharathan, Charles Maxwell-Armstrong.
Queen's Medical Centre, Nottingham, UK.
Introduction: To evaluate individual surgeon performance for laparo-
scopic colorectal operations from UK national laparoscopic training centre.
Methods: Data analysis was conducted from prospectively validated
colorectal database for the individual consultant surgeon from July 2003.
Results: 325 patients (172 male, 153 female) of mean age 65.9 years and
mean BMI of 26.5. The majority were ASA grade 2 (57.5%). 102 procedures
were right-sided, 65 left-sided, 15 involving right and left, and 143 rectal
operations. 213 were for malignancy (65.5%). The commonest stage was
Dukes' B and 92%were of curative intent withmean lymph node harvest of
13.2. Trainee was the primary surgeon in 53%. Mean postoperative length
of stay was 6.4 (1-115) days. Thirty days morbidity and in-hospital mor-
tality were 24.6% (anastomotic leak rate 2.2%), and 1.2% respectively;
readmission and reoperation rates were 9.2% and 4.6%. Conversion rate to
open was 12%; incisional hernia rate was 18.2%. 3-year local and distant
disease recurrence rates were 9.2% and 19.3% respectively. Five-year sur-
vival for cancer resections was 74.5%.
Conclusions: The results lend further evidence of the safety and efﬁcacy of
laparoscopic surgery. Laparoscopic training can be achieved with good
clinical outcomes despite the pressures for disclosure of individual sur-
geon level data.
1364: THE EFFECT OF MOVIPREPADMINISTRATION TIMING ON THE AD-
EQUACY OF BOWEL PREPARATION FOR COLONOSCOPY
Aimen Amer, Taimoor Shaﬁq*, Anthony Brown, Jonathan Kinnear,
Robin Brown, Adrian Neill, Damian Mckay, Hisham Hurreiz. Department
of General Surgery, Newry, UK.
Introduction: Colonoscopy is limited by a small but signiﬁcant incidence
of missed lesions due in part to inadequate bowel preparation. At our
endoscopy unit, bowel preparation (Moviprep) is administered 12-16 hr
prior to endoscopy for morning lists but only 6-9 hr before afternoon lists.
We aimed to investigate the effect of moviprep administration timing on
the adequacy of bowel preparation.
Methods: Data was collected for colonoscopy patients over two months.
Adequacy of bowel preparation was compared between morning and af-
ternoon lists. The effect of various independent factors on the adequacy of
bowel prep including age, gender and operator were also tested.
Results: 199 patients were included. 102 patients were scheduled on a
morning list. Within this group, the incidence of good, satisfactory and
poor bowel preparation respectively was 23.5%, 50% and 26.5% compared
to 57.7%, 24.8% and 17.5% on afternoon lists (P<0.0001). The adequacy of
